CATEEHAR
Live / Registered — Registered (as of 13 May 2025)
What this means for you
Registered since 13 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98083782
- Registration number
- 7796325
- Mark type
- Stylized text
- Filed
- 13 Jul 2023
- Published for opposition
- 23 Apr 2024
- Registered
- 13 May 2025
- Attorney of record
- Mark Rubinshtein, Ph.D.
Goods and services
- Class 005 — Pharmaceuticals: chemical preparations and reagents for pharmaceutical, medical, and clinical purposes, namely, for the prevention and treatment of cancer or combination treatment of multiple cancers; pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer(s)
Owner
- Advenchen Pharmaceuticals, LLC, Moorpark, CA, US
- Advenchen Pharmaceuticals, LLC, Moorpark, CA, US
- Advenchen Pharmaceuticals, LLC, Moorpark, CA, US
Prosecution history
- 13 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 23 Apr 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Apr 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Apr 2025 — ASSIGNED TO LIE
- 26 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Mar 2025 — NON-FINAL ACTION E-MAILED
- 07 Mar 2025 — SU - NON-FINAL ACTION - WRITTEN
- 06 Mar 2025 — ASSIGNED TO EXAMINER
- 26 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Feb 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Dec 2024 — USE AMENDMENT FILED